Biogen Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $7.43B | $10.70B | $1.33B |
| FY2021 | $6.27B | $10.90B | $2.26B |
| FY2022 | $6.28B | $13.40B | $3.42B |
| FY2023 | $6.94B | $14.80B | $1.05B |
| FY2024 | $6.30B | $16.72B | $2.38B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $7.43B | $10.70B | $1.33B |
| FY2021 | $6.27B | $10.90B | $2.26B |
| FY2022 | $6.28B | $13.40B | $3.42B |
| FY2023 | $6.94B | $14.80B | $1.05B |
| FY2024 | $6.30B | $16.72B | $2.38B |